Ishikawa Invests ¥500 Million In Flu Vaccine Maker UMN
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Ishikawa Harima Heavy Industry will invest ¥500 million in Akita-based UMN Pharma and establish a flu vaccine manufacturing joint venture